ANNA WONG: Open Payments
NPI 1194037481 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 39 payments from 6 companies in 2025. Trend: 2023 $3,759 · 2024 $1,773 · 2025 $712
Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $243 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $147 |
| Gilead Sciences, Inc. | 4 | $89 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: XIFAXAN, Kerendia, CREON, LINZESS, TRELEGY ELLIPTA, FARXIGA.
Industry payments across CA — which companies pay providers there.
